Hamburg, Germany 5 June 2025 – Clariness, a global leader in patient recruitment and clinical trial solutions, today announces the appointment of Stefan Mayer-Eggersmann as Co-CEO of Clariness. Stefan will join Co-Founder and CEO Michael Stadler, who will continue to lead the company´s strategy and innovation roadmap.
After four years of driving year-on-year growth as Chief Commercial Officer, Stefan has been appointed Co-CEO to lead both commercial and operational delivery. This appointment is a key part of Clariness’ long-term strategy to enhance customer satisfaction and patient engagement.
With the rapid development of new technologies such as artificial intelligence transforming patient recruitment, Michael will focus on shaping the future of Clariness, ensuring the company remains at the forefront of industry innovation. He will continue to oversee the Finance, HR, and Technology/Data/Product functions.
Michael Stadler, CEO and Co-Founder of Clariness, commented on his decision to appoint Stefan as Co-CEO, “Stefan has done a great job in re-building and leading our commercial team over the last 4 years. I’m confident that in his new role, Stefan will drive even greater commercial and operational successes, allowing me to focus on the next stage of strategic development for Clariness. Our commitment to innovation and technology has kept us on the forefront for 20 years. This co-leadership structure will allow us to bring even more value to our clients, our team, and most importantly, the patients we serve.”
Speaking on his new appointment as Co-CEO at Clariness, Stefan commented, “I am honored by the trust Michael and the board have placed in me. Together, we have an ambitious growth strategy and a dynamic innovation roadmap. By sharing leadership responsibilities, we are well positioned to unlock Clariness’ full potential and deliver operational excellence.”
About Clariness
Clariness provides high-end services across the clinical trial lifecycle, including study feasibility, patient recruitment, and patient retention services, for pharmaceutical companies, contract research organizations (CROs), and study sites across the globe. Dedicated to improving patients’ lives by accelerating the development of medical treatments and therapies, Clariness is the leading expert in global patient recruitment with 20 years’ experience. Clariness has supported 1,500+ clinical trials worldwide through its market leading patient portal ClinLife®, which is active in 54 countries, available in 35+ languages, and has covered 175+ indications.
For more information, visit www.clariness.com and www.clinlife.com.
About ClinLife®
ClinLife® is a patient-friendly digital platform that allows users to browse indications, find matching clinical studies and apply for them via the portal. Different sponsors, sites, CROs and digital health applications list a single study or an entire portfolio of clinical trials on ClinLife®.
Press Contact: Joseph Yeomans, SVP Marketing & Growth, [email protected]
